Literature DB >> 15108807

Ski and SnoN: negative regulators of TGF-beta signaling.

Kunxin Luo1.   

Abstract

Ski and SnoN are unique proto-oncoproteins in that they can induce both oncogenic transformation and terminal muscle differentiation when expressed at high levels. Recent studies using in vitro and in vivo approaches have begun to unravel the complex roles of Ski and SnoN in tumorigenesis and embryonic development. The identification of Ski and SnoN as important negative regulators of signal transduction by the transforming growth factor-beta superfamily of cytokines provides a valuable molecular basis for the complex functions of Ski and SnoN.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15108807     DOI: 10.1016/j.gde.2003.11.003

Source DB:  PubMed          Journal:  Curr Opin Genet Dev        ISSN: 0959-437X            Impact factor:   5.578


  88 in total

1.  Intercellular variation in signaling through the TGF-β pathway and its relation to cell density and cell cycle phase.

Authors:  Agata Zieba; Katerina Pardali; Ola Söderberg; Lena Lindbom; Erik Nyström; Aristidis Moustakas; Carl-Henrik Heldin; Ulf Landegren
Journal:  Mol Cell Proteomics       Date:  2012-03-22       Impact factor: 5.911

2.  The Smad3 linker region contains a transcriptional activation domain.

Authors:  Guannan Wang; Jianyin Long; Isao Matsuura; Dongming He; Fang Liu
Journal:  Biochem J       Date:  2005-02-15       Impact factor: 3.857

3.  Cytoplasmic SnoN in normal tissues and nonmalignant cells antagonizes TGF-beta signaling by sequestration of the Smad proteins.

Authors:  Ariel R Krakowski; Julien Laboureau; Alain Mauviel; Mina J Bissell; Kunxin Luo
Journal:  Proc Natl Acad Sci U S A       Date:  2005-08-18       Impact factor: 11.205

4.  TAK1 MAPK kinase kinase mediates transforming growth factor-beta signaling by targeting SnoN oncoprotein for degradation.

Authors:  Taisuke Kajino; Emily Omori; Shunsuke Ishii; Kunihiro Matsumoto; Jun Ninomiya-Tsuji
Journal:  J Biol Chem       Date:  2007-02-02       Impact factor: 5.157

5.  Cooperative involvement of NFAT and SnoN mediates transforming growth factor-β (TGF-β) induced EMT in metastatic breast cancer (MDA-MB 231) cells.

Authors:  Suman Sengupta; Samir Jana; Subir Biswas; Palash Kumar Mandal; Arindam Bhattacharyya
Journal:  Clin Exp Metastasis       Date:  2013-07-06       Impact factor: 5.150

6.  Spatiotemporal expression of SKIP after rat sciatic nerve crush.

Authors:  Youhua Wang; Long Long; Jiao Yang; Yajuan Wu; Hao Wu; Haixiang Wei; Xiaolong Deng; Xinghai Cheng; Dong Lou; Hailei Chen; Hai Wen
Journal:  Neurochem Res       Date:  2013-02-07       Impact factor: 3.996

7.  The predictive value of genes of the TGF-beta1 pathway in multimodally treated squamous cell carcinoma of the esophagus.

Authors:  Franziska Pühringer-Oppermann; Mario Sarbia; Nicola Ott; Björn L D M Brücher
Journal:  Int J Colorectal Dis       Date:  2009-12-15       Impact factor: 2.571

8.  Association of v-ErbA with Smad4 disrupts TGF-beta signaling.

Authors:  Richard A Erickson; Xuedong Liu
Journal:  Mol Biol Cell       Date:  2009-01-14       Impact factor: 4.138

Review 9.  To (TGF)beta or not to (TGF)beta: fine-tuning of Smad signaling via post-translational modifications.

Authors:  Katharine H Wrighton; Xin-Hua Feng
Journal:  Cell Signal       Date:  2008-02-15       Impact factor: 4.315

10.  Differential role of Sloan-Kettering Institute (Ski) protein in Nodal and transforming growth factor-beta (TGF-β)-induced Smad signaling in prostate cancer cells.

Authors:  BaoHan T Vo; Bianca Cody; Yang Cao; Shafiq A Khan
Journal:  Carcinogenesis       Date:  2012-07-27       Impact factor: 4.944

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.